BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Enanta Pharmaceuticals, Inc. 

500 Arsenal Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-607-0800 Fax: 617-607-0530


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Enanta Pharmaceuticals, Inc. Reports Financial Results For its Fiscal Fourth Quarter And Year Ended September 30, 2014 11/24/2014 9:52:16 AM
Enanta Pharmaceuticals, Inc. To Present At The Deutsche Bank (DB) 2014 BioFEST 11/21/2014 12:10:34 PM
Enanta Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results For The Fiscal Fourth Quarter And Year Ended September 30, 2014 11/17/2014 5:27:12 PM
Enanta Pharmaceuticals, Inc. Announces Results From Phase 2b PEARL-I Study In Genotype 4 Chronic Hepatitis C Patients At The Liver Meeting 2014® 11/11/2014 11:08:43 AM
Enanta Pharmaceuticals, Inc. Announces Results From TURQUOISE-I Study In Chronic Hepatitis C Patients With HIV-1 Co-Infection And From The CORAL-I Study In Liver Transplant Recipients At The Liver Meeting 2014® 11/11/2014 10:36:10 AM
Enanta Pharmaceuticals, Inc. To Present At Credit Suisse 2014 Healthcare Conference 11/6/2014 10:56:25 AM
Enanta Pharmaceuticals, Inc. Rejects HCV Drug Co-Development Option With AbbVie (ABBV) 10/20/2014 7:41:24 PM
Novartis AG (NVS) Ditches Hepatitis C Drug Dreams, Breaks $440 Million Enanta Pharmaceuticals, Inc. Deal 10/1/2014 6:28:32 AM
Enanta Pharmaceuticals, Inc. Announces The Initiation Of Phase 2b Clinical Trial With Regimen Containing HCV Protease Inhibitor ABT-493 9/10/2014 10:27:24 AM
Enanta Pharmaceuticals, Inc. To Present At Three Upcoming Investor Conferences 8/28/2014 12:34:51 PM
12345678